Cargando…
Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets: Erratum
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059100/ https://www.ncbi.nlm.nih.gov/pubmed/31265644 http://dx.doi.org/10.1097/01.md.0000503499.57465.64 |
Ejemplares similares
-
Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
por: Wang, Xiaosheng, et al.
Publicado: (2016) -
Erratum to epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer
Publicado: (2022) -
Erratum: Achilles' heel of triple negative cancer
por: Ocaña, Alberto, et al.
Publicado: (2014) -
Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
por: Zhao, Zitong, et al.
Publicado: (2023) -
Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)